Article
Otorhinolaryngology
Juhana Tikkanen, Teija Nieminen, Patrik Lassus, Mikko Tenhunen, Lasse Lehtonen, Antti Makitie
Summary: The cost of primary surgical treatment for OPSCC in Finland is 2-3 times higher than that of definitive (chemo)radiotherapy.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
(2023)
Review
Oncology
Krishnakumar Thankappan, Azhar Jan Battoo, Sivakumar Vidhyadharan, Akshay Kudpaje, Deepak Balasubramanian, Subramania Iyer
Summary: Trans-oral robotic surgery (TORS) and primary radiotherapy are two modalities used to treat early T stage oropharyngeal squamous cell carcinoma (OPSCC). Economic evaluations suggest that TORS may be a cost-effective strategy in certain scenarios, but the need for adjuvant therapy can impact cost-effectiveness.
Editorial Material
Genetics & Heredity
David J. Peace, Evgeny Izumchenko, David Sidransky
Summary: A study uses single-cell RNA sequencing to analyze human papillomavirus (HPV)-positive and -negative oropharyngeal squamous cell carcinoma, discovering significant diversity within and between tumors. In HPV-positive tumors, subsets of malignant cells are identified with undetectable HPV expression and decreased HPV-related phenotypes, potentially impacting prognosis and therapeutic response.
Article
Otorhinolaryngology
Robbie S. R. Woods, Deirdre Callanan, Hadeel Jawad, Peter Molony, Reiltin Werner, Cynthia Heffron, Linda Feeley, Patrick Sheahan
Summary: This study investigated the interaction between HPV and specific cytokeratins in crypt epithelium and found higher expression of CK7 and CK19 in HPV-positive OPSCC compared to HPV-negative disease. These findings support a potential role for these cytokeratins in the etiopathogenesis of HPV-related OPSCC.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Ping Zhou, Deng-Lin Chen, Chen-Lu Lian, San-Gang Wu, Shi-Yang Zhang
Summary: This study explores the impact of HPV status on the prognosis of early-stage OPSCC patients and its influence on local treatment strategies. The results show that patients with HPV-positive diseases have better survival outcomes regardless of the local treatment strategy. Therefore, patients with early-stage OPSCC should be informed about the advantages and disadvantages of definitive radiotherapy or radical surgery.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Medicine, General & Internal
Mu-Hung Tsai, Yung-Jen Cheng, Tzu-Hui Pao, Wei-Ting Hsueh, Helen H. W. Chen, Yuan-Hua Wu
Summary: This study compared the effectiveness of definitive chemoradiotherapy and upfront surgical treatment for advanced-stage oropharyngeal squamous cell carcinoma. The findings suggest that definitive chemoradiotherapy is comparable to upfront surgical treatment when adjusted for baseline factors associated with prognosis. Therefore, definitive chemoradiotherapy may be considered to avoid toxic effects associated with surgical treatment and chemoradiotherapy.
Article
Medicine, Research & Experimental
Ramez Philips, Hamad Sagheer, Adam Barsouk, Brian Swendseid, Jennifer Johnson, Voichita Bar Ad, Adam Luginbuhl, Joseph Curry, David Cognetti
Summary: The study found that the rate of adjuvant therapy for HPV-related oropharyngeal cancer patients has decreased over time, as well as the rate of one-year gastrostomy tube dependence. However, there was no significant difference in overall survival and disease-free survival between different time periods.
Article
Radiology, Nuclear Medicine & Medical Imaging
Ngoc-Anh Tran, Miklos Palotai, Glenn J. J. Hanna, Jonathan D. D. Schoenfeld, Camden P. P. Bay, Eleni M. M. Rettig, Paul M. M. Bunch, Amy F. F. Juliano, Hillary R. R. Kelly, Chong Hyun Suh, David A. A. Zander, Alfredo Morales Pinzon, Benjamin H. H. Kann, Raymond Y. Y. Huang, Robert I. I. Haddad, Charles R. G. Guttmann, Jeffrey P. P. Guenette
Summary: This study aims to determine the reproducible diagnostic performance of CT features for extranodal extension (ENE) in HPV-positive oropharyngeal squamous cell carcinoma (HPV + OPSCC). Five expert head/neck neuroradiologists evaluated a cohort of 75 HPV + OPSCC patients and analyzed 7 CT features associated with ENE. The results showed poor reproducibility among the experts and poor predictive value for ENE based on these CT features.
EUROPEAN RADIOLOGY
(2023)
Article
Oncology
Kathleen R. Bartemes, Benjamin R. Gochanour, David M. Routman, Daniel J. Ma, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, William R. Taylor, Douglas W. Mahoney, Calise K. Berger, Xiaoming Cao, Sara S. Then, Travis J. Haller, Alyssa M. Larish, Eric J. Moore, Joaquin J. Garcia, Rondell P. Graham, Jamie N. Bakkum-Gamez, John B. Kisiel, Kathryn M. Van Abel
Summary: This study aimed to find novel biomarkers for early identification of human papillomavirus associated oropharyngeal squamous cell carcinoma (HPV (+) OPSCC). By evaluating the expression of 21 methylated DNA markers in tissues, it was found that most markers had higher discrimination in HPV (+) cervical squamous cell carcinoma (CSCC) than in HPV (+) OPSCC.
Article
Oncology
Kimberley L. Kiong, Christopher M. K. L. Yao, Fang-Yu Lin, Diana Bell, Renata Ferrarotto, Randal S. Weber, Carol M. Lewis
Summary: A study found that a longer time to surgery (≥34 days) after neoadjuvant chemotherapy in head and neck squamous cell carcinoma patients leads to significantly worse distant metastasis-free rate and disease-free survival rate, but no significant differences in overall survival and locoregional recurrence rate.
Article
Otorhinolaryngology
Allen L. Feng, Andrew J. Holcomb, Nicholas B. Abt, Tara E. Mokhtari, Krish Suresh, Christopher McHugh, Anuraag S. Parikh, Allison Holman, Rachael E. Kammer, Tessa A. Goldsmith, Daniel L. Faden, Daniel G. Deschler, Mark A. Varvares, Derrick T. Lin, Jeremy D. Richmon
Summary: The study found that feeding tubes are rarely required after transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma. With appropriate multidisciplinary planning and care, patients can reliably avoid the need for feeding tube placement in the perioperative setting.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
(2022)
Article
Otorhinolaryngology
Yeshwant Chillakuru, Daniel A. Benito, David Strum, Varun Mehta, Prashant Saini, Timothy Shim, Christina Darwish, Arjun S. Joshi, Punam Thakkar, Joseph F. Goodman
Summary: The study found that in patients with oropharyngeal squamous cell carcinoma, those undergoing transoral robotic surgery (TORS) had better overall survival compared to those undergoing nonrobotic surgery (NRS). Specifically, TORS was associated with significantly improved survival rates in patients with base of tongue primaries.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
(2021)
Article
Medicine, Research & Experimental
Ryan M. Carey, Aman Prasad, Kimberly Wei, Jason A. Brant, Robert M. Brody, Jason M. Leibowitz, Francisco J. Civantos, Larissa Sweeny
Summary: This study aims to determine whether intensive local therapy (local surgery or radiation) has a survival benefit for patients with distantly metastatic OPSCC. The results indicate that curative dose local radiotherapy, in addition to systemic therapy, is associated with improved overall survival compared to systemic therapy alone. However, there is not a significant survival benefit for local surgery in this patient population.
Article
Medicine, Research & Experimental
Joseph S. Lu, Austin C. Cao, David Shimunov, Lova Sun, John N. Lukens, Alexander Lin, Roger B. Cohen, Devraj Basu, Steven B. Cannady, Karthik Rajasekaran, Gregory S. Weinstein, Robert M. Brody
Summary: This study aims to describe the swallowing and feeding-tube outcomes in high-risk oropharyngeal cancer patients treated with trimodality therapy, including transoral robotic surgery (TORS) and adjuvant chemoradiotherapy. The study found that functional oral intake significantly improved after treatment, and the proportion of long-term feeding tube dependence was low.
Article
Oncology
Joel C. Davies, Zain Husain, Terry A. Day, Evan M. Graboyes, Antoine Eskander
Summary: Based on the analysis of the National Cancer Database, transoral robotic surgery (TORS) has been found to be an effective treatment option for early-stage oropharyngeal squamous cell carcinoma (OPSCC), with similar survival rates to radiation therapy and reduced morbidity. However, concerns remain regarding the risk of mortality during the perioperative period.
FRONTIERS IN ONCOLOGY
(2022)